Eli Lilly (LLY.N): Novo Nordisk (NVO.N) is not competing based on the superiority or inferiority of its products, but is asking the court to prevent Eli Lilly from publishing the results of the trial.
2026-07-21
Eli Lilly (LLY.N): Novo Nordisk (NVO.N) is not competing based on the superiority or inferiority of its products, but is asking the court to prevent Eli Lilly from publishing the results of the trial.